首页> 中文期刊> 《中国实用医药》 >CsA治疗切脾治疗后复发难治性ITP临床分析

CsA治疗切脾治疗后复发难治性ITP临床分析

         

摘要

Objective To evaluate curative effect of cyclosporin A (CsA) in the treatment of relapsed refractory idiopathic thrombocytopenic purpura (RITP) after splenectomy.Methods A retrospective analysis was made on the clinical data of 3 patients with relapsed refractory ITP after splenectomy treated by CsA. Results After CsA treatment, all the 3 cases with relapsed refractory ITP after splenectomy had recovered blood platelet as normal level, without obvious adverse reactions.Conclusion Cyclosporin A can be applied as one of the safe and effective Methods in treating relapsed refractory ITP after splenectomy.%目的:评价环孢素A(CsA)治疗切脾后复发难治性特发性血小板减少性紫癜(RITP)的疗效。方法对3例CsA治疗切脾术后复发难治性ITP患者的临床资料进行回顾性分析。结果 CsA治疗后,3例切脾后复发难治性ITP患者血小板均恢复至正常水平,且无明显副作用。结论环孢素A可以作为脾切除后复发难治性ITP安全、有效的治疗手段之一。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号